Dr. Anurag Mehta, MD

Dr. Mehta practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Mehta's NPI, 1023490307, was assigned on June 23, 2015. Dr. Mehta holds Georgia license 103086.

Dr. Mehta's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Mehta's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Mehta is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Mehta to 2 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mehta is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mehta's licenses on file in 2 states: Georgia and Virginia.

CMS data shows 2,683 Medicare services from Dr. Mehta across 15 procedure codes in 2024, for 1,812 Medicare patients. Medicare paid $68,707 for them.

CMS counts 1,812 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 759 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 72, with 48% women.

In 2024, Dr. Mehta wrote 1,967 Medicare Part D claims for 248 patients. 69% of them were for generic drugs. CMS names the drug for 1,752 of them, across 33 drugs with 11 or more claims each, at $387,543 in total drug cost. In 2023, CMS named 830 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 137 papers to Dr. Mehta, published from 2010 to 2025. 2024 was the busiest year, with 21. The most frequent topics are Cardiovascular Diseases, Coronary Artery Disease and Atherosclerosis. Dr. Mehta has published most often in Am J Transplant. Dr. Mehta's most frequent co-authors are Laurence S. Sperling, MD, Arshed A. Quyyumi, MD and Devinder Singh Dhindsa.

CMS Open Payments shows 10 general payments to Dr. Mehta from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $454. It also lists 3 research payments totaling $10,115 from 2023 to 2025.